Author

J. Alter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. F. Carlin· 2 shared B. A. Croker· 2 shared M. Dassau· 2 shared M. Gal-Tanamy· 2 shared M. Mor· 2 shared M. Werbner· 2 shared S. L. Leibel· 2 shared A. Clark· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. F. Carlin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

FAK family proteins regulate in vivo breast cancer metastasis via distinct mechanisms.

A. Genna, J. Alter, M. Poletti, T. Meirson, T. Sneh, M. Gendler, N. Saleev, G. Karagiannis, Y. Wang, D. Cox, D. Entenberg, M. Oktay, T. Korcsmaros, J. Condeelis, H. Gil-Henn

This study shows that PYK2 and FAK regulate breast cancer metastasis through distinct mechanisms, with PYK2 affecting motility and FAK reducing tumor size and metastasis.

bioRxiv · Oct 27, 2023 · PreprintCancer Biology

Conformational Flexibility in Neutralization of SARS-CoV-2 by Naturally Elicited Anti-SARS-CoV-2 Antibodies

R. Li, M. Mor, B. Ma, A. E. Clark, J. Alter, M. Werbner, J. Lee, S. L. Leibel, A. F. Carlin, M. Dassau, M. Gal-Tanamy, B. A. Croker, Y. Xiang, N. T. Freund

This study evaluates the neutralizing activity of nine anti-SARS-CoV-2 monoclonal antibodies against variants of concern and reveals their structural mechanisms of action.

bioRxiv · Apr 3, 2022Immunology

Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors

M. Mor, M. Werbner, J. Alter, M. Safra, E. Chomsky, S. Hada-Neeman, K. Polonsky, C. Nowell, A. Clark, A. Roitburd-Berman, N. Ben-Shalom, M. Navon, D. Rafael, H. Sharim, E. Kiner, , N. Freund

This study identifies multi-clonal neutralizing antibodies against SARS-CoV-2 in severe COVID-19 patients and shows their potential for combination therapy.

bioRxiv · Oct 6, 2020Immunology